IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 1595 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians

Mehta Timir Y, Prajapati Laxman M, Mittal Bharti, Joshi Chaitanya G, Sheth Jayesh J, Patel Dinesh B, Dave Dinkar M, Goyal Ramesh K

Year : 2009| Volume: 75| Issue : 6 | Page no: 579-582

   This article has been cited by
 
1 Role of dermatology in pharmacogenomics: drug-induced skin injury
Riccardo G Borroni
Pharmacogenomics. 2015; 16(4): 401
[Pubmed]  [Google Scholar] [DOI]
2 Upregulated RIP3 Expression Potentiates MLKL Phosphorylation–Mediated Programmed Necrosis in Toxic Epidermal Necrolysis
Sue Kyung Kim,Woo-Jung Kim,Jung-Ho Yoon,Jae-Hoon Ji,Michael J Morgan,Hyeseong Cho,You Chan Kim,You-Sun Kim
Journal of Investigative Dermatology. 2015;
[Pubmed]  [Google Scholar] [DOI]
3 PharmGKB summary
Julia M. Barbarino,Deanna L. Kroetz,Teri E. Klein,Russ B. Altman
Pharmacogenetics and Genomics. 2015; 25(4): 205
[Pubmed]  [Google Scholar] [DOI]
4 New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity
Munir Pirmohamed,David A. Ostrov,B. Kevin Park
Journal of Allergy and Clinical Immunology. 2015; 136(2): 236
[Pubmed]  [Google Scholar] [DOI]
5 Research on Susceptible Genes and Immunological Pathogenesis of Cutaneous Adverse Drug Reactions in Chinese Hans
Fangping Yang,Ying Yang,Qinyuan Zhu,Sheng-an Chen,Xiaodan Fu,Sijia Yan,Chunjie Meng,Li Ma,Xinfen Sun,Jinhua Xu,Xiaoqun Luo,Qinghe Xing
Journal of Investigative Dermatology Symposium Proceedings. 2015; 17(1): 29
[Pubmed]  [Google Scholar] [DOI]
6 Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: An Update
Roni P. Dodiuk-Gad,Wen-Hung Chung,Laurence Valeyrie-Allanore,Neil H. Shear
American Journal of Clinical Dermatology. 2015; 16(6): 475
[Pubmed]  [Google Scholar] [DOI]
7 Stevens–Johnson syndrome and toxic epidermal necrolysis: an update on pharmacogenetics studies in drug-induced severe skin reaction
Sara Rufini,Cinzia Ciccacci,Cristina Politi,Emiliano Giardina,Giuseppe Novelli,Paola Borgiani
Pharmacogenomics. 2015; 16(17): 1989
[Pubmed]  [Google Scholar] [DOI]
8 HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese
Dinh Van Nguyen,Hieu Chi Chu,Doan Van Nguyen,Minh Hong Phan,Timothy Craig,Karl Baumgart,Sheryl van Nunen
Asia Pacific Allergy. 2015; 5(2): 68
[Pubmed]  [Google Scholar] [DOI]
9 GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy
Hui Won Jang,So Won Kim,Yang-Je Cho,Kyoung Heo,Byung In Lee,Sang Kun Lee,In-Jin Jang,Min Goo Lee,Won-Joo Kim,Ji Hyun Lee
Epilepsy Research. 2015; 115: 88
[Pubmed]  [Google Scholar] [DOI]
10 Evolving models of the immunopathogenesis of T cell–mediated drug allergy: The role of host, pathogens, and drug response
Katie D. White,Wen-Hung Chung,Shuen-Iu Hung,Simon Mallal,Elizabeth J. Phillips
Journal of Allergy and Clinical Immunology. 2015; 136(2): 219
[Pubmed]  [Google Scholar] [DOI]
11 Genetic screening for human leukocyte antigen alleles prior to carbamazepine treatment
Jeremy C.K. Tan,Dedee F. Murrell,Mark I. Hersch
Journal of Clinical Neuroscience. 2015; 22(12): 1992
[Pubmed]  [Google Scholar] [DOI]
12 Recent advances of pharmacogenomics in severe cutaneous adverse reactions: immune and nonimmune mechanisms
Ro-Lan Dao,Shih-Chi Su,Wen-Hung Chung
Asia Pacific Allergy. 2015; 5(2): 59
[Pubmed]  [Google Scholar] [DOI]
13 Identification of Stevens-Johnson syndrome and toxic epidermal necrolysis in electronic health record databases
Robert L. Davis,Mia A. Gallagher,Maryam M. Asgari,Melody J. Eide,David J. Margolis,Eric Macy,James K. Burmester,Nandini Selvam,Joseph A. Boscarino,Lee F. Cromwell,Heather S. Feigelson,Jennifer L. Kuntz,Pamala A. Pawloski,Robert B. Penfold,Marsha A. Raebel,Gayathri Sridhar,Ann Wu,Lois A. La Grenade,Michael A. Pacanowski,Simone P. Pinheiro
Pharmacoepidemiology and Drug Safety. 2015; 24(7): 684
[Pubmed]  [Google Scholar] [DOI]
14 Fever, Rash, and Systemic Symptoms: Understanding the Role of Virus and HLA in Severe Cutaneous Drug Allergy
Rebecca Pavlos,Simon Mallal,David Ostrov,Yuri Pompeu,Elizabeth Phillips
The Journal of Allergy and Clinical Immunology: In Practice. 2014; 2(1): 21
[Pubmed]  [Google Scholar] [DOI]
15 Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions
Ursula Amstutz,Neil H. Shear,Michael J. Rieder,Soomi Hwang,Vincent Fung,Hidefumi Nakamura,Mary B. Connolly,Shinya Ito,Bruce C. Carleton
Epilepsia. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
16 Genetics of Immune-Mediated Adverse Drug Reactions: a Comprehensive and Clinical Review
V. L. M. Yip,A. Alfirevic,M. Pirmohamed
Clinical Reviews in Allergy & Immunology. 2014;
[Pubmed]  [Google Scholar] [DOI]
17 Association of carbamazepine-induced severe cutaneous drug reactions and HLA-B*1502 allele status, and dose and treatment duration in paediatric neurology patients in Singapore
K. W. Chong,D. W. S. Chan,Y. B. Cheung,L. K. Ching,S. L. Hie,T. Thomas,S. Ling,E. C. Tan
Archives of Disease in Childhood. 2014; 99(6): 581
[Pubmed]  [Google Scholar] [DOI]
18 Association of HLA-B*1502 and *1511 allele with antiepileptic drug-induced Stevens-Johnson syndrome in central China
Dan Sun,Chun-hua Yu,Zhi-sheng Liu,Xue-lian He,Jia-sheng Hu,Ge-fei Wu,Bing Mao,Shu-hua Wu,Hui-hui Xiang
Journal of Huazhong University of Science and Technology [Medical Sciences]. 2014; 34(1): 146
[Pubmed]  [Google Scholar] [DOI]
19 Digging Up the Human Genome: Current Progress in Deciphering Adverse Drug Reactions
Shih-Chi Su,Wen-Hung Chung,Shuen-Iu Hung
BioMed Research International. 2014; 2014: 1
[Pubmed]  [Google Scholar] [DOI]
20 Building pharmacogenetics into a pharmacovigilance program in Singapore: using serious skin rash as a pilot study
D S L Toh,L L Tan,D C W Aw,S M Pang,S H Lim,T Thirumoorthy,H Y Lee,Y K Tay,S K Tan,A Vasudevan,A Lateef,Y Y Chong,Y C Chan,C Loke,C L Chan,E S C Koay,E C Ren,E J D Lee,C Sung
The Pharmacogenomics Journal. 2014;
[Pubmed]  [Google Scholar] [DOI]
21 International Consensus on drug allergy
P. Demoly,N. F. Adkinson,K. Brockow,M. Castells,A. M. Chiriac,P. A. Greenberger,D. A. Khan,D. M. Lang,H.-S. Park,W. Pichler,M. Sanchez-Borges,T. Shiohara,B. Y.-H. Thong
Allergy. 2014; 69(4): 420
[Pubmed]  [Google Scholar] [DOI]
22 Ancestry-based pharmacogenomics, adverse reactions and carbamazepine: is the FDA warning correct?
P W Payne
The Pharmacogenomics Journal. 2014;
[Pubmed]  [Google Scholar] [DOI]
23 Association ofHLA-B*1502allele with lamotrigine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese subjects: a meta-analysis
Tao Zeng,Yue-Sheng Long,Fu-Li Min,Wei-Ping Liao,Yi-Wu Shi
International Journal of Dermatology. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
24 Antiepileptic drugs and adverse skin reactions: An update
Barbara Blaszczyk,Wladyslaw Lason,Stanislaw Jerzy Czuczwar
Pharmacological Reports. 2014;
[Pubmed]  [Google Scholar] [DOI]
25 HLA-B*1502 is associated with carbamazepine induced Stevens–Johnson syndrome in North Indian population
Ritu Aggarwal,Madhulika Sharma,Manish Modi,Vivek kumar Garg,Manilla Salaria
Human Immunology. 2014; 75(11): 1120
[Pubmed]  [Google Scholar] [DOI]
26 Clinical features of and genetic predisposition to drug-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a single Korean tertiary institution patients—investigating the relation between the HLA -B*4403 allele and lamotrigine
Hye Jung Park,Sung Ryeol Kim,Dong Woo Leem,Il Joo Moon,Beom Seok Koh,Kyung Hee Park,Jung-Won Park,Jae-Hyun Lee
European Journal of Clinical Pharmacology. 2014;
[Pubmed]  [Google Scholar] [DOI]
27 HLA-B*15:02 association with carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in an Indian population: a pooled-data analysis and meta-analysis
Amy Hui-Ping Khor,Kheng-Seang Lim,Chong-Tin Tan,Su-Ming Wong,Ching-Ching Ng
Epilepsia. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
28 Personalized Pharmacogenomics: Predicting Efficacy and Adverse Drug Reactions
Munir Pirmohamed
Annual Review of Genomics and Human Genetics. 2014; 15(1): 349
[Pubmed]  [Google Scholar] [DOI]
29 Pharmacogenetics of antiepileptic drug-induced hypersensitivity
Katarzyna M Bloch,Graeme J Sills,Munir Pirmohamed,Ana Alfirevic
Pharmacogenomics. 2014; 15(6): 857
[Pubmed]  [Google Scholar] [DOI]
30 Genetic predictors of Stevens–Johnson syndrome and toxic epidermal necrolysis induced by aromatic antiepileptic drugs among the Chinese Han population
Wei Wang,Fa-Yun Hu,Xin-Tong Wu,Dong-Mei An,Bo Yan,Dong Zhou
Epilepsy & Behavior. 2014; 37: 16
[Pubmed]  [Google Scholar] [DOI]
31 Rapid detection ofHLA-A*31:01allele in DNA and blood samples using loop-mediated isothermal amplification
Y.K. Cheung,M. Kwok,E. Chan,P. Kwan
British Journal of Dermatology. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
32 Genotyping for Severe Drug Hypersensitivity
Eric Karlin,Elizabeth Phillips
Current Allergy and Asthma Reports. 2014; 14(3)
[Pubmed]  [Google Scholar] [DOI]
33 Hypersensitivity to Antiepileptic Drugs
Young-Min Ye,Bernard Yu-Hor Thong,Hae-Sim Park
Immunology and Allergy Clinics of North America. 2014;
[Pubmed]  [Google Scholar] [DOI]
34 Pharmacogenetics: a reality or misplaced optimism?
S. MUTSATSA,T. J. CURRID
Journal of Psychiatric and Mental Health Nursing. 2013; 20(4): 314
[Pubmed]  [Google Scholar] [DOI]
35 Human leukocyte antigen-associated drug hypersensitivity
Patricia T Illing,Julian P Vivian,Anthony W Purcell,Jamie Rossjohn,James McCluskey
Current Opinion in Immunology. 2013; 25(1): 81
[Pubmed]  [Google Scholar] [DOI]
36 Development of a Simple Method for Detection of the HLA-A*31:01 Allele
Kazuki UCHIYAMA,Fumika KUBOTA,Noritaka ARIYOSHI,Jun MATSUMOTO,Itsuko ISHII,Mitsukazu KITADA
Drug Metabolism and Pharmacokinetics. 2013; 28(5): 435
[Pubmed]  [Google Scholar] [DOI]
37 Stevens-Johnson syndrome / toxic epidermal necrolysis: an Asia-Pacific perspective
Bernard Yu-Hor Thong
Asia Pacific Allergy. 2013; 3(4): 215
[Pubmed]  [Google Scholar] [DOI]
38 Toxic epidermal necrolysis
Robert A. Schwartz,Patrick H. McDonough,Brian W. Lee
Journal of the American Academy of Dermatology. 2013; 69(2): 173.e1
[Pubmed]  [Google Scholar] [DOI]
39 Update on pathobiology in Stevens-Johnson syndrome and toxic epidermal necrolysis
Shih-Chi Su,Wen-Hung Chung
Dermatologica Sinica. 2013; 31(4): 175
[Pubmed]  [Google Scholar] [DOI]
40 Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury
Nahoko Kaniwa,Yoshiro Saito
Journal of Human Genetics. 2013; 58(6): 317
[Pubmed]  [Google Scholar] [DOI]
41 Proton pump inhibitors are associated with hypersensitivity reactions to drugs in hospitalized patients: a nested case-control in a retrospective cohort study
E. Ramírez,R. Cabañas,L. S. Laserna,A. Fiandor,H. Tong,N. Prior,O. Calderón,N. Medrano,I. Bobolea,J. Frías,S. Quirce
Clinical & Experimental Allergy. 2013; 43(3): 344
[Pubmed]  [Google Scholar] [DOI]
42 Toxic epidermal necrolysis
Haur-Yueh Lee,Wen-Hung Chung
Current Opinion in Allergy and Clinical Immunology. 2013; : 1
[Pubmed]  [Google Scholar] [DOI]
43 Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Carbamazepine Dosing
S G Leckband,J R Kelsoe,H M Dunnenberger,A L George,E Tran,R Berger,D J Müller,M Whirl-Carrillo,K E Caudle,M Pirmohamed
Clinical Pharmacology & Therapeutics. 2013; 94(3): 324
[Pubmed]  [Google Scholar] [DOI]
44 HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese
Ying-Kit Cheung,Suk-Hang Cheng,Ernest J. M. Chan,Su V. Lo,Margaret H. L. Ng,Patrick Kwan
Epilepsia. 2013; 54(7): 1307
[Pubmed]  [Google Scholar] [DOI]
45 Pharmacogenomics of severe cutaneous adverse reactions
Nahoko Kaniwa,Yoshiro Saito
Pharmacogenomics. 2013; 14(6): 595
[Pubmed]  [Google Scholar] [DOI]
46 HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis
E Genin,D-P Chen,S-I Hung,P Sekula,M Schumacher,P-Y Chang,S-H Tsai,T-L Wu,T Bellón,R Tamouza,C Fortier,A Toubert,D Charron,A Hovnanian,P Wolkenstein,W-H Chung,M Mockenhaupt,J-C Roujeau
The Pharmacogenomics Journal. 2013;
[Pubmed]  [Google Scholar] [DOI]
47 Simple and rapid detection of HLA-A*31:01 for prediction of carbamazepine-induced hypersensitivity using loop-mediated isothermal amplification method
Hiroyuki NIIHARA,Kunie KOHNO,Takeshi TAKETANI,Sakae KANEKO,Takahumi ITO,Takashi SUGAMORI,Nobuyuki TAKAHASHI,Tuyoshi MIYAOKA,Shihoh OKAZAKI,Hideaki YASUDA,Motohide FURUYA,Michiharu NAGAHAMA,Eishin MORITA
Journal of Dermatological Science. 2013;
[Pubmed]  [Google Scholar] [DOI]
48 Specific HLA types are associated with antiepileptic drug-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in Japanese subjects
Nahoko Kaniwa,Emiko Sugiyama,Yoshiro Saito,Kouichi Kurose,Keiko Maekawa,Ryuichi Hasegawa,Hirokazu Furuya,Hiroko Ikeda,Yukitoshi Takahashi,Masaaki Muramatsu,Masahiro Tohkin,Takeshi Ozeki,Taisei Mushiroda,Michiaki Kubo,Naoyuki Kamatani,Masamichi Abe,Akiko Yagami,Mayumi Ueta,Chie Sotozono,Shigeru Kinoshita,Zenro Ikezawa,Kayoko Matsunaga,Michiko Aihara
Pharmacogenomics. 2013; 14(15): 1821
[Pubmed]  [Google Scholar] [DOI]
49 HLA-A*31:01 and HLA-B*15:02 as Genetic Markers for Carbamazepine Hypersensitivity in Children
U Amstutz,C J D Ross,L I Castro-Pastrana,M J Rieder,N H Shear,M R Hayden,B C Carleton
Clinical Pharmacology & Therapeutics. 2013; 94(1): 142
[Pubmed]  [Google Scholar] [DOI]
50 Dermatologic Side Effects of Psychotropic Medications
Mario V. Mitkov,Ryan M. Trowbridge,Benjamin N. Lockshin,Jason P. Caplan
Psychosomatics. 2013;
[Pubmed]  [Google Scholar] [DOI]
51 HLA and disease: guilt by association
W. M. Howell
International Journal of Immunogenetics. 2013; : n/a
[Pubmed]  [Google Scholar] [DOI]
52 Genotype–phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: Strength and clinical correlations
Yi-Hsin Hsiao,Rosaline Chung-Yee Hui,Tony Wu,Wan-Chun Chang,Mo-Song Hsih,Chih-Hsun Yang,Hsin-Chun Ho,Ya-Ging Chang,Ming-Jing Chen,Jing-Yi Lin,Ding-Ping Chen,Pi-Yueh Chang,Tsu-Lan Wu,Shuen-Iu Hung,Wen-Hung Chung
Journal of Dermatological Science. 2013;
[Pubmed]  [Google Scholar] [DOI]
53 Association between the HLA-B*15:02 allele and carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Han individuals of northeastern China
Xiao-Jing He,Ling-Yan Jian,Xiao-Lin He,Yan Wu,Yuan-Yuan Xu,Xiao-Jie Sun,Li-Yan Miao,Li-Mei Zhao
Pharmacological Reports. 2013; 65(5): 1256
[Pubmed]  [Google Scholar] [DOI]
54 Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis
Wen-Hung Chung,Shuen-Iu Hung
Journal of Dermatological Science. 2012; 66(3): 190
[Pubmed]  [Google Scholar] [DOI]
55 Association between HLA and Stevens-Johnson Syndrome Induced by Carbamazepine in Southern Han Chinese: Genetic Markers besides B*1502?
Yi-Wu Shi,Fu-Li Min,Bin Qin,Xin Zou,Xiao-Rong Liu,Mei-Mei Gao,Qian Wang,Jue-Qian Zhou,Wei-Ping Liao
Basic & Clinical Pharmacology & Toxicology. 2012; : n/a
[Pubmed]  [Google Scholar] [DOI]
56 A Review of Pharmacogenetics of Adverse Drug Reactions in Elderly People
Maurizio Cardelli,Francesca Marchegiani,Andrea Corsonello,Fabrizia Lattanzio,Mauro Provinciali
Drug Safety. 2012; 35(S1): 3
[Pubmed]  [Google Scholar] [DOI]
57 Genetic and immune predictors for hypersensitivity syndrome to antiepileptic drugs
Manuela G. Neuman,Lawrence Cohen,Radu M. Nanau,Paul A. Hwang
Translational Research. 2012; 159(5): 397
[Pubmed]  [Google Scholar] [DOI]
58 Using companion and coupled diagnostics within strategy to personalize targeted medicines
Donald RJ Singer,John Watkins
Personalized Medicine. 2012; 9(7): 751
[Pubmed]  [Google Scholar] [DOI]
59 HLA and pharmacogenetics of drug hypersensitivity
Rebecca Pavlos,Simon Mallal,Elizabeth Phillips
Pharmacogenomics. 2012; 13(11): 1285
[Pubmed]  [Google Scholar] [DOI]
60 Drug Hypersensitivity and Human Leukocyte Antigens of the Major Histocompatibility Complex
Mandvi Bharadwaj,Patricia Illing,Alex Theodossis,Anthony W. Purcell,Jamie Rossjohn,James McCluskey
Annual Review of Pharmacology and Toxicology. 2012; 52(1): 401
[Pubmed]  [Google Scholar] [DOI]
61 The structural basis of HLA-associated drug hypersensitivity syndromes
Yuri A. Pompeu,Jon D. Stewart,Simon Mallal,Elizabeth Phillips,Bjoern Peters,David A. Ostrov
Immunological Reviews. 2012; 250(1): 158
[Pubmed]  [Google Scholar] [DOI]
62 Pharmacogenetic screening to prevent carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome: a critical appraisal
K. Wu,N.J. Reynolds
British Journal of Dermatology. 2012; 166(1): 7
[Pubmed]  [Google Scholar] [DOI]
63 Genetic and immune predictors for hypersensitivity syndrome to antiepileptic drugs
Neuman, M.G., Cohen, L., Nanau, R.M., Hwang, P.A.
Translational Research. 2012; 159(5): 397-406
[Pubmed]  [Google Scholar]
64 Combinatorial approach for predicting antiepileptic drug specific hypersensitivity
[No author name available]
Pharmacogenomics. 2012; 13(5): 520-521
[Pubmed]  [Google Scholar]
65 HLA-B*1502 allele is associated with a cross-reactivity pattern of cutaneous adverse reactions to antiepileptic drugs
Wang, J., Zhang, J., Wu, X., Yu, P., Hong, Z.
Journal of International Medical Research. 2012; 40(1): 377-382
[Pubmed]  [Google Scholar]
66 A recent update of pharmacogenomics in drug-induced severe skin reactions
Wei, C.-Y., Ko, T.-M., Shen, C.-Y., Chen, Y.-T.
Drug Metabolism and Pharmacokinetics. 2012; 27(1): 132-141
[Pubmed]  [Google Scholar]
67 Genome-wide mapping for clinically relevant predictors of lamotrigine-and phenytoin-induced hypersensitivity reactions
McCormack, M., Urban, T.J., Shianna, K.V., Walley, N., Pandolfo, M., Depondt, C., Chaila, E., (...), Cavalleri, G.L.
Pharmacogenomics. 2012; 13(4): 399-405
[Pubmed]  [Google Scholar]
68 Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex
Bharadwaj, M., Illing, P., Theodossis, A., Purcell, A.W., Rossjohn, J., McCluskey, J.
Annual Review of Pharmacology and Toxicology. 2012; 52: 401-431
[Pubmed]  [Google Scholar]
69 HLA-B*1502 Strongly Predicts Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain
Kulkantrakorn, K., Tassaneeyakul, W., Tiamkao, S., Jantararoungtong, T., Prabmechai, N., Vannaprasaht, S., Chumworathayi, P., (...), Sritipsukho, P.
Pain Practice. 2012; 12(3): 202-208
[Pubmed]  [Google Scholar]
70 Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: Treatment outcomes
Tan, S.-K., Tay, Y.-K.
Acta Dermato-Venereologica. 2012; 92(1): 62-66
[Pubmed]  [Google Scholar]
71 Pharmacogenetic screening to prevent carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome: A critical appraisal
Wu, K., Reynolds, N.J.
British Journal of Dermatology. 2012; 166(1): 7-11
[Pubmed]  [Google Scholar]
72 Genome-wide mapping for clinically relevant predictors of lamotrigine- and phenytoin-induced hypersensitivity reactions
Mark McCormack,Thomas J Urban,Kevin V Shianna,Nicole Walley,Massimo Pandolfo,Chantal Depondt,Elijah Chaila,Gerard D O’Conner,Dalia Kasperaviciute,Rodney A Radtke,Erin L Heinzen,Sanjay M Sisodiya,Norman Delanty,Gianpiero L Cavalleri
Pharmacogenomics. 2012; 13(4): 399
[Pubmed]  [Google Scholar] [DOI]
73 Research Highlights: Highlights from the latest articles on pharmacogenetic studies of antiepileptic drugs
Sandeep Grover,Ritushree Kukreti
Pharmacogenomics. 2012; 13(5): 519
[Pubmed]  [Google Scholar] [DOI]
74 Integration of Pharmacogenetics and Pharmacogenomics in Drug Development: Implications for Regulatory and Medical Decision Making in Pediatric Diseases
Chiara Piana,Linda Surh,Sabine Furst-Recktenwald,Achille Iolascon,Evelyne M. Jacqz-Aigrain,Ineke Jonker,Roberta Russo,Ron H.N. van Schaik,Judith Wessels,Oscar E. Della Pasqua
The Journal of Clinical Pharmacology. 2012; 52(5): 704
[Pubmed]  [Google Scholar] [DOI]
75 T-cell receptor and carbamazepine-induced Stevens–Johnson syndrome and toxic epidermal necrolysis: understanding a hypersensitivity reaction
Tai-Ming Ko,Yuan-Tsong Chen
Expert Review of Clinical Immunology. 2012; 8(5): 467
[Pubmed]  [Google Scholar] [DOI]
76 A Recent Update of Pharmacogenomics in Drug-induced Severe Skin Reactions
Chun-Yu WEI,Tai-Ming KO,Chen-Yang SHEN,Yuan-Tsong CHEN
Drug Metabolism and Pharmacokinetics. 2012; 27(1): 132
[Pubmed]  [Google Scholar] [DOI]
77 HLA-A31 strongly associates with carbamazepine-induced adverse drug reactions but not with carbamazepine-induced lymphocyte proliferation in a Japanese population
Hiroyuki NIIHARA,Takeyasu KAKAMU,Yasuyuki FUJITA,Sakae KANEKO,Eishin MORITA
The Journal of Dermatology. 2012; 39(7): 594
[Pubmed]  [Google Scholar] [DOI]
78 Severe drug eruptions revisited
Sebastien Calbo
Immunologic Research. 2012; 53(1-3): 162
[Pubmed]  [Google Scholar] [DOI]
79 HLA Genotype and Carbamazepine-Induced Cutaneous Adverse Drug Reactions: A Systematic Review
V L Yip,A G Marson,A L Jorgensen,M Pirmohamed,A Alfirevic
Clinical Pharmacology & Therapeutics. 2012; 92(6): 757
[Pubmed]  [Google Scholar] [DOI]
80 HLA-B*1502 Strongly Predicts Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain
Kongkiat Kulkantrakorn,Wichittra Tassaneeyakul,Somsak Tiamkao,Thawinee Jantararoungtong,Napat Prabmechai,Suda Vannaprasaht,Pansu Chumworathayi,Pei Chen,Paskorn Sritipsukho
Pain Practice. 2012; 12(3): 202
[Pubmed]  [Google Scholar] [DOI]
81 Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome
Chun-Yu Wei,Wen-Hung Chung,Hsiao-Wen Huang,Yuan-Tsong Chen,Shuen-Iu Hung
Journal of Allergy and Clinical Immunology. 2012; 129(6): 1562
[Pubmed]  [Google Scholar] [DOI]
82 Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking
S. A. Walsh,D. Creamer
Clinical and Experimental Dermatology. 2011; 36(1): 6
[Pubmed]  [Google Scholar] [DOI]
83 Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans
Sae-Hoon Kim,Kyung Wha Lee,Woo-Jung Song,Sang-Heon Kim,Young-Koo Jee,Sang-Min Lee,Hye-Ryun Kang,Heung-Woo Park,Sang-Heon Cho,Seong-Ho Park,Kyung-Up Min,Yoon-Seok Chang
Epilepsy Research. 2011; 97(1-2): 190
[Pubmed]  [Google Scholar] [DOI]
84 Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan
Pei Chen,Juei-Jueng Lin,Chin-Song Lu,Cheung-Ter Ong,Peiyuan F. Hsieh,Chih-Chao Yang,Chih-Ta Tai,Shey-Lin Wu,Cheng-Hsien Lu,Yung-Chu Hsu,Hsiang-Yu Yu,Long-Sun Ro,Chung-Ta Lu,Chun-Che Chu,Jing-Jane Tsai,Yu-Hsiang Su,Sheng-Hsing Lan,Sheng-Feng Sung,Shu-Yi Lin,Hui-Ping Chuang,Li-Chen Huang,Ying-Ju Chen,Pei-Joung Tsai,Hung-Ting Liao,Yu-Hsuan Lin,Chien-Hsiun Chen,Wen-Hung Chung,Shuen-Iu Hung,Jer-Yuarn Wu,Chi-Feng Chang,Luke Chen,Yuan-Tsong Chen,Chen-Yang Shen
New England Journal of Medicine. 2011; 364(12): 1126
[Pubmed]  [Google Scholar] [DOI]
85 The Genetics of Antiepileptic Drug–Induced Skin Reactions
S Hakimian,J W Miller
Clinical Pharmacology & Therapeutics. 2011; 89(6): 908
[Pubmed]  [Google Scholar] [DOI]
86 Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome
Tai-Ming Ko,Wen-Hung Chung,Chun-Yu Wei,Han-Yu Shih,Jung-Kuei Chen,Chia-Hsien Lin,Yuan-Tsong Chen,Shuen-Iu Hung
Journal of Allergy and Clinical Immunology. 2011; 128(6): 1266
[Pubmed]  [Google Scholar] [DOI]
87 Pharmacogenetics of cutaneous adverse drug reactions
Michiko AIHARA
The Journal of Dermatology. 2011; 38(3): 246
[Pubmed]  [Google Scholar] [DOI]
88 Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients
Yan Zhang,Jin Wang,Li-Mei Zhao,Wei Peng,Guo-Qing Shen,Ling Xue,Xiao-Xian Zheng,Xiao-Jing HE,Chun-Yan Gong,Li-Yan Miao
European Journal of Clinical Pharmacology. 2011; 67(9): 885
[Pubmed]  [Google Scholar] [DOI]
89 HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
Mark McCormack,Ana Alfirevic,Stephane Bourgeois,John J. Farrell,Dalia Kasperaviciute,Mary Carrington,Graeme J. Sills,Tony Marson,Xiaoming Jia,Paul I.W. de Bakker,Krishna Chinthapalli,Mariam Molokhia,Michael R. Johnson,Gerard D. OæConnor,Elijah Chaila,Saud Alhusaini,Kevin V. Shianna,Rodney A. Radtke,Erin L. Heinzen,Nicole Walley,Massimo Pandolfo,Werner Pichler,B. Kevin Park,Chantal Depondt,Sanjay M. Sisodiya,David B. Goldstein,Panos Deloukas,Norman Delanty,Gianpiero L. Cavalleri,Munir Pirmohamed
New England Journal of Medicine. 2011; 364(12): 1134
[Pubmed]  [Google Scholar] [DOI]
90 PharmGKB summary
Caroline F. Thorn,Susan G. Leckband,John Kelsoe,J. Steven Leeder,Daniel J. Müller,Teri E. Klein,Russ B. Altman
Pharmacogenetics and Genomics. 2011; 21(12): 906
[Pubmed]  [Google Scholar] [DOI]
91 Analysis of Body Constitution of Fifty-two Patients with Stevens-Johnson Syndrome (SJS) Using Kampo Medical Questionnaires: Prediction of SJS based on Body Constitution Using Decision Tree
Shigeru OHSHIMA,Yukiko HATORI,Seiichi HONMA,Katsutoshi TERASAWA,Yukiya SAITOH,Daisuke KOBAYASHI
YAKUGAKU ZASSHI. 2011; 131(5): 745
[Pubmed]  [Google Scholar] [DOI]
92 Phenytoin-induced Stevens–Johnson syndrome with negative HLA-B*1502 allele in mainland China: Two cases
Fa-Yun Hu,Xin-Tong Wu,Dong-Mei An,Bo Yan,Hermann Stefan,Dong Zhou
Seizure. 2011; 20(5): 431
[Pubmed]  [Google Scholar] [DOI]
93 Pilot association study of oxcarbazepine-induced mild cutaneous adverse reactions with HLA-B*1502 allele in Chinese Han population
Fa-yun Hu,Xin-tong Wu,Dong-mei An,Bo Yan,Hermann Stefan,Dong Zhou
Seizure. 2011; 20(2): 160
[Pubmed]  [Google Scholar] [DOI]
94 Exploratory Study on Biomarkers Associated with Severe Cutaneous Adverse Reactions
Nahoko KANIWA
YAKUGAKU ZASSHI. 2011; 131(2): 255
[Pubmed]  [Google Scholar] [DOI]
95 Epidemiology and risk factors for drug allergy
Bernard Y-H. Thong,Teck-Choon Tan
British Journal of Clinical Pharmacology. 2011; 71(5): 684
[Pubmed]  [Google Scholar] [DOI]
96 Carbamazepine-induced Stevens-Johnson syndrome: Genetic predisposition of Asian patients | [Stevens-Johnson-syndrom unter carbamazepin: Genetische prädisposition asiatischer patienten]
Spindelegger, C., Konstantinidis, A., Kasper, S.
Journal fur Neurologie, Neurochirurgie und Psychiatrie. 2011; 12(2): 176-178
[Pubmed]  [Google Scholar]
97 Carbamzepine-induced toxic epidermal necrolysis
Chowta, N.K., Chowta, M.N., Ramapuram, J., Kumar, P., Fazil, A.
Indian Journal of Critical Care Medicine. 2011; 15(2): 123-125
[Pubmed]  [Google Scholar]
98 Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury
M Pirmohamed,P S Friedmann,M Molokhia,Y K Loke,C Smith,E Phillips,L La Grenade,B Carleton,M Papaluca-Amati,P Demoly,N H Shear
Clinical Pharmacology & Therapeutics. 2011; 89(6): 896
[Pubmed]  [Google Scholar] [DOI]
99 Toxic epidermal necrolysis and Stevens-Johnson syndrome: A review*
Roland Gerull,Mathias Nelle,Thomas Schaible
Critical Care Medicine. 2011; 39(6): 1521
[Pubmed]  [Google Scholar] [DOI]
100 Drug reaction with eosinophilia and systemic symptoms (DRESS): A clinical update and review of current thinking
Walsh, S.A., Creamer, D.
Clinical and Experimental Dermatology. 2011; 36(1): 6-11
[Pubmed]  [Google Scholar]
101 Phenotype standardization for immune-mediated drug-induced skin injury
Pirmohamed, M., Friedmann, P.S., Molokhia, M., Loke, Y.K., Smith, C., Phillips, E., La Grenade, L., (...), Shear, N.H.
Clinical Pharmacology and Therapeutics. 2011; 89(6): 896-901
[Pubmed]  [Google Scholar]
102 Analysis of body constitution of fifty-two patients with stevens-johnson syndrome (SJS) using kampo medical questionnaires: Prediction of SJS based on body constitution using decision tree
Ohshima, S., Hatori, Y., Honma, S., Terasawa, K., Saitoh, Y., Kobayashi, D.
Yakugaku Zasshi. 2011; 131(5): 745-756
[Pubmed]  [Google Scholar]
103 Epidemiology and risk factors for drug allergy
Thong, B.Y.-H., Tan, T.-C.
British Journal of Clinical Pharmacology. 2011; 71(5): 684-700
[Pubmed]  [Google Scholar]
104 HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans
McCormack, M., Alfirevic, A., Bourgeois, S., Farrell, J.J., Kasperavičiute, D., Carrington, M., Sills, G.J., (...), Pirmohamed, M.
New England Journal of Medicine. 2011; 364(12): 1134-1143
[Pubmed]  [Google Scholar]
105 Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan
Chen, P., Lin, J.-J., Lu, C.-S., Ong, C.-T., Hsieh, P.F., Yang, C.-C., Tai, C.-T., (...), Shen, C.-Y.
New England Journal of Medicine. 2011; 364(12): 1126-1133
[Pubmed]  [Google Scholar]
106 Pharmacogenetics of cutaneous adverse drug reactions
Aihara, M.
Journal of Dermatology. 2011; 38(3): 246-254
[Pubmed]  [Google Scholar]
107 Pilot association study of oxcarbazepine-induced mild cutaneous adverse reactions with HLA-B*1502 allele in Chinese Han population
Hu, F.-Y., Wu, X.-T., An, D.-M., Yan, B., Stefan, H., Zhou, D.
Seizure. 2011; 20(2): 160-162
[Pubmed]  [Google Scholar]
108 Drug hypersensitivity: Pharmacogenetics and clinical syndromes
Phillips, E.J., Chung, W.-H., Mockenhaupt, M., Roujeau, J.-C., Mallal, S.A.
Journal of Allergy and Clinical Immunology. 2011; 127(3 sup): s60-s66
[Pubmed]  [Google Scholar]
109 Drug induced hypersensitivity and the HLA complex
Alfirevic, A., Pirmohamed, M.
Pharmaceuticals. 2011; 4(1): 69-90
[Pubmed]  [Google Scholar]
110 Exploratory study on biomarkers associated with severe cutaneous adverse reactions
Kaniwa, N.
Yakugaku Zasshi. 2011; 131(2): 255-261
[Pubmed]  [Google Scholar]
111 Do no harm-But first we need to know more: The case of adverse drug reactions with antiepileptic drugs
Singh, G.
Neurology India. 2011; 59(1): 53-58
[Pubmed]  [Google Scholar]
112 Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans
Kim, S.-H., Lee, K.W., Song, W.-J., Kim, S.-H., Jee, Y.-K., Lee, S.-M., Kang, H.-R., (...), Chang, Y.-S.
Epilepsy Research. 2011; 97(1-2): 190-197
[Pubmed]  [Google Scholar]
113 Strong association between HLA-Bz.ast1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients
Zhang, Y., Wang, J., Zhao, L.-M., Peng, W., Shen, G.-Q., Xue, L., Zheng, X.-X., (...), Miao, L.-Y.
European Journal of Clinical Pharmacology. 2011; 67(9): 885-887
[Pubmed]  [Google Scholar]
114 Antiepileptic drugs
Zaccara, G., Tramacere, L.
Side Effects of Drugs Annual. 2011; 33(1): 125-204
[Pubmed]  [Google Scholar]
115 Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome
Ko, T.-M., Chung, W.-H., Wei, C.-Y., Shih, H.-Y., Chen, J.-K., Lin, C.-H., Chen, Y.-T., Hung, S.-I.
Journal of Allergy and Clinical Immunology. 2011; 128(6): 1266-1276
[Pubmed]  [Google Scholar]
116 PharmGKB summary: Carbamazepine pathway
Thorn, C.F., Leckband, S.G., Kelsoe, J., Steven Leeder, J., Müller, D.J., Klein, T.E., Altman, R.B.
Pharmacogenetics and Genomics. 2011; 21(12): 906-910
[Pubmed]  [Google Scholar]
117 Phenytoin-induced Stevens-Johnson syndrome with negative HLA-B*1502 allele in mainland China: Two cases
Hu, F.-Y., Wu, X.-T., An, D.-M., Yan, B., Stefan, H., Zhou, D.
Seizure. 2011; 20(5): 431-432
[Pubmed]  [Google Scholar]
118 The genetics of antiepileptic drug-induced skin reactions
Hakimian, S., Miller, J.W.
Clinical Pharmacology and Therapeutics. 2011; 89(6): 908-910
[Pubmed]  [Google Scholar]
119 Toxic epidermal necrolysis and Stevens-Johnson syndrome: A review
Gerull, R., Nelle, M., Schaible, T.
Critical Care Medicine. 2011; 39(6): 1521-1532
[Pubmed]  [Google Scholar]
120 Drug Induced Hypersensitivity and the HLA Complex
Ana Alfirevic,Munir Pirmohamed
Pharmaceuticals. 2010; 4(1): 69
[Pubmed]  [Google Scholar] [DOI]
121 Carbamazepine-induced Stevens-Johnson syndrome sparing the skin previously affected by herpes zoster infection in a patient with systemic lupus erythematosus: A reverse isotopic phenomenon
Tenea, D.
Case Reports in Dermatology. 2010; 2(2): 140-145
[Pubmed]  [Google Scholar]
122 Association study of lamotrigine-induced cutaneous adverse reactions and HLA-B*1502 in a Han Chinese population
An, D.-M., Wu, X.-T., Hu, F.-Y., Yan, B., Stefan, H., Zhou, D.
Epilepsy Research. 2010; 92(2-3): 226-230
[Pubmed]  [Google Scholar]
123 HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients
Kaniwa, N., Saito, Y., Aihara, M., Matsunaga, K., Tohkin, M., Kurose, K., Furuya, H., (...), Hasegawa, R.
Epilepsia. 2010; 51(12): 2461-2465
[Pubmed]  [Google Scholar]
124 Genetic markers and danger signals in Stevens-Johnson syndrome and toxic epidermal necrolysis
Chung, W.-H., Hung, S.-I.
Allergology International. 2010; 59(4): 325-332
[Pubmed]  [Google Scholar]
125 Association study of lamotrigine-induced cutaneous adverse reactions and HLA-B*1502 in a Han Chinese population
Dong-Mei An,Xin-Tong Wu,Fa-Yun Hu,Bo Yan,Hermann Stefan,Dong Zhou
Epilepsy Research. 2010; 92(2-3): 226
[Pubmed]  [Google Scholar] [DOI]
126 HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients
Nahoko Kaniwa,Yoshiro Saito,Michiko Aihara,Kayoko Matsunaga,Masahiro Tohkin,Kouichi Kurose,Hirokazu Furuya,Yukitoshi Takahashi,Masaaki Muramatsu,Shigeru Kinoshita,Masamichi Abe,Hiroko Ikeda,Mariko Kashiwagi,Yixuan Song,Mayumi Ueta,Chie Sotozono,Zenro Ikezawa,Ryuichi Hasegawa
Epilepsia. 2010; 51(12): 2461
[Pubmed]  [Google Scholar] [DOI]
127 Genetic and ethnic risk factors associated with drug hypersensitivity
Kim, S.-H., Ye, Y.-M., Palikhe, N.S., Kim, J.-E., Park, H.-S.
Current Opinion in Allergy and Clinical Immunology. 2010; 10(4): 280-290
[Pubmed]  [Google Scholar]
128 Genetic Markers and Danger Signals in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Wen-Hung Chung,Shuen-Iu Hung
Allergology International. 2010; 59(4): 325
[Pubmed]  [Google Scholar] [DOI]
129 Genetic and ethnic risk factors associated with drug hypersensitivity
Seung-Hyun Kim,Young-Min Ye,Nami Shrestha Palikhe,Jeong-Eun Kim,Hae-Sim Park
Current Opinion in Allergy and Clinical Immunology. 2010; 10(4): 280
[Pubmed]  [Google Scholar] [DOI]

 

Online since 15th March '04
Published by Wolters Kluwer - Medknow